The utility of fractional exhaled nitric oxide suppression in the identification of nonadherence in difficult asthma.
about
Chinese expert consensus on clinical use of non-invasive airway inflammation assessment in bronchial asthmaChinese expert consensus on clinical use of non-invasive airway inflammation assessment in bronchial asthmaA method to assess adherence in inhaler use through analysis of acoustic recordings of inhaler eventsTargeting patients with asthma for omalizumab therapy: choosing the right patient to get the best value for money.Data-driven asthma endotypes defined from blood biomarker and gene expression data.Nonadherence in difficult asthma - facts, myths, and a time to act.Inhaled corticosteroids in lung diseases.Validated and longitudinally stable asthma phenotypes based on cluster analysis of the ADEPT study.Non-adherence in difficult asthma and advances in detection.Biomarkers of eosinophilic inflammation in asthma.Can biomarkers help us hit targets in difficult-to-treat asthma?The current and future role of biomarkers in type 2 cytokine-mediated asthma management.Improving the diagnosis of eosinophilic asthma.How to manage a child with difficult asthma?Clinical management of severe therapy-resistant asthma.Update in asthma 2012.Assessing adherence to inhaled medication in difficult-to-treat asthma.Measuring adherence to inhaled corticosteroids in asthma: getting closer!Predictive Biomarkers for Asthma Therapy.Management of severe asthma: targeting the airways, comorbidities and risk factors.Xerostomia relates to the degree of asthma control.Practical phenotyping of difficult asthma.
P2860
Q26771615-CFB2A8D9-79BF-4739-A9DB-389FACF83E42Q26772201-D09756DA-AD63-473A-9CC1-7C3B7BAE7F2AQ28539467-9321EE3C-92E7-43D6-A704-183664BFC4B7Q30360362-9F2154DF-BDDE-48E5-9F46-EF25431EEF7AQ30887089-D8ED6166-5CBD-4D18-9779-7190FF5A39A0Q36883787-64723DB4-6561-4B3F-B1D8-DDF2EEFECF40Q36999789-AE78EAF6-754D-47A6-9B2B-857D891A5999Q37508900-8ADBA1C3-C43C-4243-9539-F51B7CE81D21Q38155878-E3DC16A3-60F8-4EF1-A67C-194080C9B47CQ38181529-E52D4A7B-49EC-4903-B967-3F490438C462Q38752058-62825CFE-2B1D-44AF-9470-682BD7F0761AQ38764451-2E0C1463-CA07-4838-B6BF-CB2FA40384ADQ38821540-51B9B25F-CE9C-47CA-AAAA-6542A9819CB6Q38845918-3E8B63B9-ED02-4F3B-AD29-173822DDB963Q39226704-832BA9E9-CCE0-43AC-953A-89A8BB17F8E9Q42283781-383836B2-A15A-443A-B151-C8061263C8DBQ43997345-1CA7D8A1-AF00-48ED-8612-3BC97E561A81Q45367191-7A2F6094-7560-4144-BFB3-E64A48A0CACAQ47683405-F3E839B0-1048-4BF7-AD48-31F297ED2E81Q47724148-6415B9D8-9448-4EE6-92C3-66B255786256Q48067214-BD8B8C37-A564-4597-9772-8D0BC8B6FEC3Q50479644-ED35EACA-12D0-4D0A-B6DD-1F8F8855BABD
P2860
The utility of fractional exhaled nitric oxide suppression in the identification of nonadherence in difficult asthma.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
The utility of fractional exha ...... adherence in difficult asthma.
@en
The utility of fractional exha ...... adherence in difficult asthma.
@nl
type
label
The utility of fractional exha ...... adherence in difficult asthma.
@en
The utility of fractional exha ...... adherence in difficult asthma.
@nl
prefLabel
The utility of fractional exha ...... adherence in difficult asthma.
@en
The utility of fractional exha ...... adherence in difficult asthma.
@nl
P2093
P2860
P1476
The utility of fractional exha ...... adherence in difficult asthma.
@en
P2093
Diarmuid M McNicholl
Liam G Heaney
Lorcan P McGarvey
Michael Stevenson
P2860
P304
P356
10.1164/RCCM.201204-0587OC
P407
P577
2012-09-28T00:00:00Z